VIA EDGAR
Division of Corporation Finance
Securities and Exchange Commission
December 27, 2019
Attention | : Lisa Vanjoske |
Mary Mast
Re: | Sanofi |
Form 20-F for Fiscal Year Ended December 31, 2018 |
Filed March 8, 2019 |
File No. 001-31368 |
Dear Ms. Vanjoske, Dear Ms. Mast:
This is a reply to your letter dated December 20, 2019 addressed to Mr. Paul Hudson, Chief Executive Officer of Sanofi.
This letter confirms that, as Ms. Vanjoske and Linda Hesse discussed on December 22, 2019, Sanofi is in the process of gathering information responsive to the Staff’s aforementioned comment letter and intends to respond no later than January 15, 2020.
Please do not hesitate to contact Linda Hesse from Jones Day at +33 1 56 59 38 72 if you have any questions.
Very truly yours, |
/s/ Alexandra Roger |
Alexandra Roger |
Head of Securities Law and Capital Markets |
Cc: | Laurent Gilhodes, Head of Group Controlling & Alliances |
Hervé Cardelli, Head of Consolidation and Statutory Reporting |